Cargando…

Effectiveness of omalizumab in an asthmatic patient with severe airway and blood eosinophilia

Detalles Bibliográficos
Autores principales:	Kupryś-Lipińska, Izabela, Kołacińska-Flont, Marta, Marczak, Jerzy, Górski, Paweł, Kurmanowska, Zofia, Kuna, Piotr
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2015
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4697022/ https://www.ncbi.nlm.nih.gov/pubmed/26755915 http://dx.doi.org/10.5114/pdia.2015.48072

Ejemplares similares

New approach to intermittent and mild asthma therapy: evolution or revolution in the GINA guidelines?
por: Kuprys-Lipinska, Izabela, et al.
Publicado: (2020)

Good outcomes of pregnancy in two cases of women treated with omalizumab due to the severe asthma
por: Kuprys-Lipinska, Izabela, et al.
Publicado: (2013)

Loss of asthma control after cessation of omalizumab treatment: real life data
por: Kupryś-Lipińska, Izabela, et al.
Publicado: (2014)

Effectiveness of the Polish program for the treatment of severe allergic asthma with omalizumab: a single-center experience
por: Kupryś-Lipińska, Izabela, et al.
Publicado: (2016)

Omalizumab in pregnant women treated due to severe asthma: two case reports of good outcomes of pregnancies
por: Kupryś-Lipińska, Izabela, et al.
Publicado: (2014)

Omalizumab therapy in a patient with severe asthma and co-existing chronic obstructive pulmonary disease
por: Kupryś-Lipińska, Izabela, et al.
Publicado: (2018)

Effectiveness of omalizumab in a patient with a life-threatening episode of bronchospasm and larynx angioedema after exposure to house dust
por: Kupryś-Lipińska, Izabela, et al.
Publicado: (2014)

Exhaled breath 8-isoprostane as a marker of asthma severity
por: Piotrowski, Wojciech J., et al.
Publicado: (2012)

A comparison of cyst wall curettage and en bloc excision in the treatment of aneurysmal bone cysts
por: Flont, Pawel, et al.
Publicado: (2013)

Exhaled 8-isoprostane as a prognostic marker in sarcoidosis. A short term follow-up
por: Piotrowski, Wojciech J, et al.
Publicado: (2010)

Expression of cPLA(2)γ mRNA and protein differs the response of PBMC from severe and non-severe asthmatics to bacterial lipopolysaccharide and house dust mite allergen
por: Pniewska-Dawidczyk, Ewa, et al.
Publicado: (2021)

Effectiveness and adverse events of plasmapheresis and immunoglobulin G infusion in patient with resistant chronic urticaria and angioedema - a case report
por: Kuprys-Lipinska, Izabela, et al.
Publicado: (2015)

Exhaled 8-isoprostane in sarcoidosis: relation to superoxide anion production by bronchoalveolar lavage cells
por: Piotrowski, Wojciech J., et al.
Publicado: (2010)

The whole - genome expression analysis of peripheral blood mononuclear cells from aspirin sensitive asthmatics versus aspirin tolerant patients and healthy donors after in vitro aspirin challenge
por: Wieczfinska, Joanna, et al.
Publicado: (2015)

Prevalence, risk factors and underdiagnosis of asthma in the general population aged over 60 years
por: Kuprys-Lipinska, Izabela, et al.
Publicado: (2019)

Rhinosinusitis in COPD: symptoms, mucosal changes, nasal lavage cells and eicosanoids
por: Piotrowska, Violetta M, et al.
Publicado: (2010)

The association between airway eosinophilic inflammation and IL-33 in stable non-atopic COPD
por: Tworek, Damian, et al.
Publicado: (2018)

Omalizumab in patients with severe asthma and persistent sputum eosinophilia
por: Mukherjee, Manali, et al.
Publicado: (2019)

Asthmatic adult with marked blood eosinophilia: is it truly asthma?
por: Tan, Shera, et al.
Publicado: (2018)

Changes in blood eosinophilia during omalizumab therapy as a predictor of asthma exacerbation
por: Skiepko, Roman, et al.
Publicado: (2014)

Peripheral blood eosinophilia in adult asthmatic patients and its association with the severity of asthma
por: Solomon, Yenealem, et al.
Publicado: (2023)

The Step Further to Understand the Role of Cytosolic Phospholipase A(2) Alpha and Group X Secretory Phospholipase A(2) in Allergic Inflammation: Pilot Study
por: Pniewska, Ewa, et al.
Publicado: (2014)

The position paper of the Polish Society of Allergology on climate changes, natural disasters and allergy and asthma
por: Pałczyński, Cezary, et al.
Publicado: (2018)

Polish Society of Allergology statement on the diagnosis and treatment of severe, difficult-to-control bronchial asthma
por: Kupczyk, Maciej, et al.
Publicado: (2019)

Expression of Transcript Variants of PTGS1 and PTGS2 Genes among Patients with Chronic Rhinosinusitis with Nasal Polyps
por: Pietruszewska, Wioletta, et al.
Publicado: (2021)

Efficacy of Omalizumab Therapy in an Asthmatic with Low IgE
por: R, Divya, et al.
Publicado: (2020)

Metabolomic applied to omalizumab effect in severe asthmatics – a preliminary result
por: Loureiro, Cláudia Chaves, et al.
Publicado: (2013)

Effective omalizumab treatment influenced eosinophil function in severe allergic asthmatics
por: Yan, Huacheng, et al.
Publicado: (2023)

287 Nasal Nitric Oxide Levels after Lysine Aspirin Nasal Challenge in Subjects with Aspirin Induced Asthma
por: Tworek, Damian, et al.
Publicado: (2012)

Influence of the diagnosis chronic rhinosinusitis on asthma response to omalizumab in severe, uncontrolled asthmatics
por: Sintobin, Ina, et al.
Publicado: (2015)

Short-Term Reproducibility of the Inflammatory Phenotype in Different Subgroups of Adult Asthma Cohort
por: Majewski, Sebastian, et al.
Publicado: (2015)

COVID-19 in two severe asthmatics receiving benralizumab: busting the eosinophilia myth
por: Renner, Andreas, et al.
Publicado: (2020)

Overexpression of chitotriosidase and YKL-40 in peripheral blood and sputum of healthy smokers and patients with chronic obstructive pulmonary disease
por: Majewski, Sebastian, et al.
Publicado: (2019)

The effect of peripheral blood eosinophilia on inflammatory markers in asthmatic patients with lower respiratory tract infections
por: Cag, Yakup, et al.
Publicado: (2019)

Follow-up of asthma control and quality of life after discontinuation of omalizumab in severe asthmatic patients
por: Nayci, Sibel, et al.
Publicado: (2015)

Omalizumab in an allergology clinic: real life experience and future developments
por: Kupczyk, Maciej, et al.
Publicado: (2014)

Involvement of Transforming Growth Factor-β-Associated Kinase 1 in Fixed Airway Obstruction in Asthmatic Patients with Longer Disease Duration Independent on Airway Eosinophilia
por: Maneechotesuwan, Kittipong, et al.
Publicado: (2023)

The effect of levocetirizine and montelukast on clinical symptoms, serum level and skin expression of COX-1 and COX-2 enzymes in patients suffering from chronic autoimmune urticaria – a pilot study
por: Korczyñska-Krawczyk, Paulina, et al.
Publicado: (2018)

P87 - A national multicenter registration of treatment with omalizumab in Danish asthmatic children
por: Spangenberg, Katrine B, et al.
Publicado: (2014)

Chronic oral corticosteroids use and persistent eosinophilia in severe asthmatics from the Belgian severe asthma registry
por: Graff, S., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mdirbv5l8oi9om076sdam0pc0u